Danielle Ronco
Psychiatric/Mental Health · Saint Louis, MONPI 1326462714
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 386 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,993 and has fallen 99.2% since, to $15 in 2025. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 386 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$915
- Otsuka America Pharmaceutical, Inc.$719
- Lundbeck LLC$692
- Takeda Pharmaceuticals U.S.A., Inc.$542
- Supernus Pharmaceuticals, Inc.$420
- plus $2K from 14 others
What the payments were for
- Food & beverage$6,34599%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 98 | $1,054 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 48 | $915 |
| Otsuka America Pharmaceutical, Inc. | 47 | $719 |
| Lundbeck LLC | 37 | $692 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $542 |
| Supernus Pharmaceuticals, Inc. | 24 | $420 |
| Vanda Pharmaceuticals Inc. | 23 | $399 |
| Alkermes, Inc. | 16 | $379 |
| Sunovion Pharmaceuticals Inc. | 21 | $360 |
| Corium, LLC | 8 | $202 |
| Tris Pharma Inc | 9 | $147 |
| Axsome Therapeutics, Inc. | 6 | $147 |
| Almatica Pharma LLC | 4 | $93 |
| Neurocrine Biosciences, Inc. | 3 | $84 |
| Idorsia Pharmaceuticals US Inc | 5 | $70 |
| Avanir Pharmaceuticals, Inc. | 3 | $40 |
| Ironshore Pharmaceuticals Inc. | 2 | $36 |
| Eisai Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $30 |
| Johnson & Johnson | 1 | $28 |
How this compares
$6,392 in reported general payments places this provider in the 90th percentile of 565 psychiatric/mental health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 31 | $639 |
| Aripiprazole | 11 | $618 |
| Divalproex Sodium | 18 | $482 |
| Bupropion XlBupropion Hcl | 22 | $133 |
| Clonazepam | 14 | $64 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Saint Louis
- Aldijana SacicSaint Louis$510K
- Julie WaterburySaint Louis$135K
- Melinda SmithSaint Louis$13K
- Richard YakimoSaint Louis$10K
- Yevgeniya MykhaylevskaSaint Louis$9K
- Anastasia AmiramovaSaint Louis$9K
- Jessica BurichSaint Louis$8K
- Jennifer ArmstrongSaint Louis$8K
- Bonnie HuffSaint Louis$7K
- Jacqueline KirkSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.